Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer

In patients with NMIBC, markers of systemic inflammation response are associated with disease recurrence and progression. The inclusion of such markers in prognostic models does enhance their accuracy.